Timothy Vogler, DPM
Foot & Ankle Surgery · Winston Salem, NCNPI 1780638700
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,698 of the $9,304 with a category attached, or 82.7%. Orthofix Medical, Inc. accounts for 64.2% of it on its own, with 14 other manufacturers making up the rest.
Across 72 payments — averaging $129.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$6K
- Stryker$1K
- Piedmont Plus Innovation$648
- Biotissue Holdings Inc.$539
- Arthrex$293
- Amgen$168
- plus $223 from 9 others
Across 3 payments — averaging $5781.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotissue Holdings Inc.$17K
What the payments were for
- Travel & lodging$7,69883%
- Food & beverage$1,58617%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 41 | $5,974 |
| Stryker | 10 | $1,459 |
| Piedmont Plus Innovation | 3 | $648 |
| Biotissue Holdings Inc. | 1 | $539 |
| Arthrex | 3 | $293 |
| Amgen(2 entities) | 2 | $168 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $53 |
| Smith+Nephew | 3 | $53 |
| Johnson & Johnson | 1 | $25 |
| Sanara Medtech Inc. | 1 | $20 |
| Reapplix Inc. | 1 | $17 |
| KCI USA, Inc. | 1 | $17 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| Next Science LLC | 1 | $13 |
| Medela LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$5,930
- PRIME SERIES$1,255
- Prokera$539
- AmnioGraft$539
- AmnioGuard$539
- TL-HEX TRUELOK HEXAPOD SYSTEM$112
How this compares
$9,304 in reported general payments places this provider in the 75th percentile of 196 foot & ankle surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 19 | $560 |
| Gabapentin | 45 | $416 |
| Doxycycline Hyclate | 46 | $387 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $316 |
| Clindamycin Hcl | 27 | $286 |
| Meloxicam | 47 | $177 |
| Cephalexin | 16 | $102 |
| Methylprednisolone | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Winston Salem
- Robert GoeckerWinston Salem$11K
- John BonvillianWinston Salem$11K
- Devon NiewohnerWinston Salem$10K
- Robert OlsonGastonia$473K
- Austin MatthewsLumberton$279K
- Matthew DzurikWilmington$142K
- Kristen McGinnessFayetteville$123K
- William RespessGreenville$79K
- Brian FutrellCary$71K
- Kenneth BloomMooresville$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.